A Qualitative Study on the Differences Between Trial Populations and the Approved Therapeutic Indications of Antineoplastic Agents by 3 Regulatory Agencies From 2010 to 2018.
Sumi E, Asada R, Lu Y, Ito-Ihara T, Grimes KV. Clin Ther. 2020 Feb;42(2):305-320.e0. doi: 10.1016/j.clinthera.2020.01.002. Epub 2020 Jan 31. PMID: 32008723. [PubMed]